Zacks: Brokerages Expect Biodesix, Inc. (NASDAQ:BDSX) Will Post Quarterly Sales of $6.88 Million
Equities research analysts predict that Biodesix, Inc. (NASDAQ:BDSX – Get Rating) will post $6.88 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Biodesix’s earnings, with estimates ranging from $6.60 million to $7.15 million. Biodesix reported sales of $28.87 million during the same quarter last year, which […]